Ashtead, United Kingdom

Benoit Maurice Mullet

This inventor holds 1 USPTO granted patent. Top assignee: The Procter Gamble Company. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benoit Maurice Mullet. Retrieved from https://idiyas.com/inventor/benoit-maurice-mullet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Benoit Maurice Mullet

Introduction: Benoit Maurice Mullet is a notable inventor based in Ashtead, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid compositions that enhance drug delivery. His work focuses on creating stable formulations that improve patient compliance and dosing accuracy.

Latest Patents: Benoit holds a patent for an orally administered liquid pharmaceutical composition. This innovative composition demonstrates excellent physical stability while delivering concentrated levels of pharmaceutical actives. Notably, the formulation does not require agitation or shaking prior to use, ensuring even and consistent dosing without the risk of active ingredients precipitating or settling out of solution. This patent highlights his commitment to improving pharmaceutical formulations.

Career Highlights: Benoit Maurice Mullet is associated with The Procter & Gamble Company, where he applies his expertise in pharmaceutical sciences. His work at this esteemed company has allowed him to contribute to advancements in consumer health products. His innovative approach has garnered attention within the industry, showcasing his ability to address complex challenges in drug formulation.

Collaborations: Benoit has collaborated with esteemed colleagues such as Douglas Joseph Dobrozsi and Jerry William Hayes, II. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.

Conclusion: Benoit Maurice Mullet's contributions to pharmaceutical innovations exemplify the importance of stability and efficacy in drug delivery systems. His patent for orally administered liquid compositions represents a significant advancement in the field, demonstrating his dedication to improving patient care. Through his work, Benoit continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…